Le Lézard
Classified in: Health, Science and technology, Business
Subject: VEN

SmithRx raises $9 million in series A funding


SAN FRANCISCO, Jan. 11, 2018 /PRNewswire/ -- SmithRx, a San Francisco based technology company and Pharmacy Benefit Manager (PBM), today announced that it has secured $9 million in Series A funding. Founders Fund led the investment round with participation from Blumberg Capital, NextGen Venture Partners, Box Group, and others. The financing will support SmithRx as it scales and delivers a broad technology solution to change the way pharmacy benefits are managed.

"We see a huge opportunity to move the PBM space forward," says Jake Frenz, SmithRx founder and CEO. Americans spent $460B at the pharmacy in 2016 according to QuintilesIMS, which is almost double the spend from 10 years ago. Consolidation in the industry, aimed at lowering cost through scale, has not mitigated this problem. "From limited choice, to antiquated technology, to dissatisfaction amongst clients and members, this is one of the largest, yet least recognized problems in healthcare." SmithRx offers a new path.

SmithRx was founded in 2016 to create a technology-driven and cost-competitive PBM that offers clients a flexible customer-centric product. "Our focus is on building the next generation pharmacy benefits partner that enables choice, aligns incentives, and surfaces insights to improve care delivery," says Frenz. "Innovation has lagged in the PBM sector, and our team is dedicated to accelerating change."

SmithRx is a talented team of industry veterans and forward-thinking engineers. The 100% in-house team also features front-line clinicians that guide plan execution and member support. "Our operations look and feel different," says Frenz. The customer experience is based on real-time data and concierge customer support that resolve member issues with speed.

"A smith is a craftsman -- someone who is precise about his or her trade," said Frenz. "That's where our company name comes from." SmithRx embodies these characteristics and brings precision to the pharmacy benefit industry by leveraging technology and data to forge the product of the future.

About SmithRx

SmithRx is the next-generation pharmacy benefit partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It's a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product. For more information visit smithrx.com.

CONTACT: [email protected]

 

SOURCE SmithRx


These press releases may also interest you

at 16:05
Huntington Bancshares Incorporated announced that the Board of Directors declared a quarterly cash dividend on the company's common stock of $0.155 per common share, unchanged from the prior quarter.  The common stock cash dividend is payable July...

at 16:00
CHAR Technologies Ltd. ("CHAR" or the "Company") a recognized leader in sustainable bioenergy solutions, announces that the Board of Directors has approved the grant of 1,116,159 stock options to employees, consultants, directors and officers of...

at 15:40
Athabasca Minerals Inc. ("Athabasca" or the "Corporation") announced today that it has applied to delist its common shares (the "Common Shares") from the TSX Venture Exchange (the "TSXV"). The delisting is being pursued in accordance with the terms...

at 15:32
Kent Outdoors ("Kent" or the "Company"), which has been helping people in their pursuit of outdoor adventures for more than 60 years, today announced a $100 million credit facility from asset-based lender (ABL) Eclipse Business Capital. The new ABL...

at 15:25
Six Flags Entertainment Corporation today announced it will release first quarter financial results before the market opens on Thursday, May 9, 2024. An investor conference call will follow beginning at 7:00 a.m. Central Time. The call can be...

at 15:15
A motion has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) under the Mutual Fund Dealer Rules in the matter of Clive Wilkins. The motion is open to the public, unless the hearing panel orders...



News published on and distributed by: